PGP
HUMA icon

Prescott General Partners’s Humacyte HUMA Stock Holding History

Prescott General Partners’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-568,246
Closed -$1.77M – 10
2024
Q1 		$1.77M Hold
568,246
– – 0.1% 7
2023
Q4 		$1.61M Hold
568,246
– – 0.09% 8
2023
Q3 		$1.66M Hold
568,246
– – 0.11% 9
2023
Q2 		$1.63M Hold
568,246
– – 0.1% 9
2023
Q1 		$1.76M Hold
568,246
– – 0.14% 9
2022
Q4 		$1.2M Hold
568,246
– – 0.1% 9
2022
Q3 		$1.85M Hold
568,246
– – 0.15% 9
2022
Q2 		$1.82M Sell
568,246
-56,854
-9% -$316K 0.13% 9
2022
Q1 		$4.41M Buy
625,100
+545,100
+681% +$3.17M 0.2% 9
2021
Q4 		$580K Buy
+80,000
New +$791K 0.02% 11

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Prescott General Partners's HUMA Position: Q2 2024 in Review

Prescott General Partners sold out of Humacyte (HUMA) in Q2 2024, closing a stake of 568,246 shares — an estimated $1.77M sold.

Prescott General Partners first reported a position in HUMA in Q4 2021 and held it in 10 quarters. The position peaked at $4.41M in Q1 2022. 123 funds tracked by Wall St. Rank hold HUMA as of Q2 2024.

  • Prescott General Partners reported no remaining Humacyte position as of Q2 2024 after selling out during the quarter.
  • Prescott General Partners sold 568,246 Humacyte shares in Q2 2024, an estimated $1.77M.
  • Prescott General Partners first reported a position in Humacyte in Q4 2021 and held it in 10 quarters.
  • Prescott General Partners's Humacyte position peaked at $4.41M in Q1 2022.
  • 123 funds tracked by Wall St. Rank held Humacyte as of Q2 2024.

Based on Prescott General Partners's 13F filing for Q2 2024, filed 14 Aug 2024.